A comprehensive view of Greiner Bio-One International GmbH. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Greiner achieves ‘solid’ sales of €2.1B for 2023 financial year, but with revenue in all three divisions--Greiner Packaging, NEVEON, Greiner Bio-One--falling short of expectations due to declining demand; Greiner notes challenging market environment
Published:
May 07, 2024
by Greiner AG
|
Greiner notes that 2023 marks the first time the group as a whole has been rated by EcoVadis, including Greiner Packaging, Greiner Bio-One and NEVEON divisions; Greiner scores 73 out of 100 points, giving it gold status
Published:
October 24, 2023
by Greiner AG
|
Greiner announces that 33 new apprentices have begun their careers at its training center in Kremsmünster, Austria; apprentices will be trained for Greiner Packaging, Greiner Bio-One and NEVEON
Published:
October 20, 2023
by Greiner AG
|
Greiner highlights installation of photovoltaic plants at eight Austrian production sites and offices across its three divisions--Greiner Packaging, Greiner Bio-One and NEVEON; plants generate 2.7 GWh of electricity/year
Published:
August 29, 2023
by Greiner AG
|
Greiner Bio-One International announces CEO Rainer Perneker to step down from position, leave company on August 28; Greiner AG COO Manfred Stanek to take over as head of the medical products division on an interim basis until a successor is appointed
Published:
July 20, 2023
by Greiner AG
|
Ask us about our Health Care Sector market view